Healthcare provider profile · identity verified

Erin Little, NP

Nurse Practitioner · TOMS RIVER, NJ · NPI 1962023929

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	233	48
Levothyroxine Sodium	Levothyroxine Sodium	223	49
Eliquis	Apixaban	174	19
Gabapentin	Gabapentin	173	34
Amlodipine Besylate	Amlodipine Besylate	167	39
Furosemide	Furosemide	158	41
Pantoprazole Sodium	Pantoprazole Sodium	149	52
Metoprolol Succinate	Metoprolol Succinate	134	34
Potassium Chloride	Potassium Chloride	133	29
Trazodone Hcl	Trazodone Hcl	118	23
Mirtazapine	Mirtazapine	114	24
Sertraline Hcl	Sertraline Hcl	113	25
Metformin Hcl	Metformin Hcl	103	35
Lisinopril	Lisinopril	98	24
Rosuvastatin Calcium	Rosuvastatin Calcium	97	27
Hydralazine Hcl	Hydralazine Hcl	94	18
Clopidogrel	Clopidogrel Bisulfate	93	20
Montelukast Sodium	Montelukast Sodium	87	14
Metoprolol Tartrate	Metoprolol Tartrate	86	24
Carvedilol	Carvedilol	83	12
Tramadol Hcl	Tramadol Hcl	81	27
Alprazolam	Alprazolam	71	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	15
Oxycodone Hcl	Oxycodone Hcl	63	14
Simvastatin	Simvastatin	58	13
Escitalopram Oxalate	Escitalopram Oxalate	56	19
Donepezil Hcl	Donepezil Hcl	52	suppressed
Lorazepam	Lorazepam	51	17
Spironolactone	Spironolactone	49	12
Losartan Potassium	Losartan Potassium	48	12
Omeprazole	Omeprazole	48	18
Doxycycline Hyclate	Doxycycline Hyclate	46	37
Xarelto	Rivaroxaban	45	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Bumetanide	Bumetanide	40	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	40	15
Doxazosin Mesylate	Doxazosin Mesylate	39	suppressed
Clonidine	Clonidine	38	suppressed
Farxiga	Dapagliflozin Propanediol	38	suppressed
Levetiracetam	Levetiracetam	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Benazepril Hcl	Benazepril Hcl	37	suppressed
Diltiazem Hcl	Diltiazem Hcl	37	suppressed
Prednisone	Prednisone	37	23
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	36	suppressed
Ezetimibe	Ezetimibe	36	11
Famotidine	Famotidine	36	15
Ondansetron Hcl	Ondansetron Hcl	36	17
Buspirone Hcl	Buspirone Hcl	34	11
Clonazepam	Clonazepam	32	12
Januvia	Sitagliptin Phosphate	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Midodrine Hcl	Midodrine Hcl	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	30	suppressed
Trulicity	Dulaglutide	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Latanoprost	Latanoprost	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Risperidone	Risperidone	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	23	suppressed
Nyamyc	Nystatin	23	suppressed
Torsemide	Torsemide	23	suppressed
Baclofen	Baclofen	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	19
Clozapine	Clozapine	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Finasteride	Finasteride	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Nystatin	Nystatin	18	11
Albuterol Sulfate Hfa	Albuterol Sulfate	17	11
Cephalexin	Cephalexin	17	14
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Temazepam	Temazepam	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Levofloxacin	Levofloxacin	16	13
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Mesalamine	Mesalamine	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Retacrit	Epoetin Alfa-Epbx	14	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methimazole	Methimazole	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Metolazone	Metolazone	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error